Michal Mandelboim
Overview
Explore the profile of Michal Mandelboim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
4340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung C, et al.
Nat Commun
. 2025 Feb;
16(1):1610.
PMID: 39948338
The COVID-19 pandemic and relevant non-pharmaceutical interventions (NPIs) interrupted the circulation of common respiratory viruses. These viruses demonstrated an unprecedented asynchronous resurgence as NPIs were relaxed. We compiled a global...
2.
Erster O, Shkedi O, Benedek G, Zilber E, Varkovitzky I, Shirazi R, et al.
PLoS One
. 2024 Nov;
19(11):e0314219.
PMID: 39541366
[This corrects the article DOI: 10.1371/journal.pone.0249149.].
3.
Gur-Arie L, Stein M, Sefty H, Fratty I, Nemet I, Kliker L, et al.
Euro Surveill
. 2024 Aug;
29(32).
PMID: 39119719
BackgroundA new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic.AimWe aimed to evaluate the performance of this platform with respect...
4.
Azziz-Baumgartner E, Hirsch A, Yoo Y, Peretz A, Greenberg D, Avni Y, et al.
Euro Surveill
. 2024 Aug;
29(31).
PMID: 39092531
BackgroundHealthcare personnel (HCP) are at high risk for respiratory infections through occupational exposure to respiratory viruses.AimWe used data from a prospective influenza vaccine effectiveness study in HCP to quantify the...
5.
Moirangthem R, Cordela S, Khateeb D, Shor B, Kosik I, Schneidman-Duhovny D, et al.
Mol Ther
. 2024 Aug;
32(10):3712-3728.
PMID: 39086132
Targeting multiple viral proteins is pivotal for sustained suppression of highly mutable viruses. In recent years, broadly neutralizing antibodies that target the influenza virus hemagglutinin and neuraminidase glycoproteins have been...
6.
Jurkowicz M, Cohen H, Nemet I, Keller N, Leibovitz E, Sherman G, et al.
J Med Virol
. 2024 Jun;
96(6):e29709.
PMID: 38828947
This study evaluated the epidemiological and clinical characteristics of human metapneumovirus (hMPV) infection among hospitalized patients with acute respiratory infections during 2015-2021 and assessed the impact of the coronavirus disease...
7.
Shteyer E, Mor O, Waisbourd-Zinman O, Mozer-Glazberg Y, Arnon R, Hecht Sagie L, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793689
Background And Aims: An increase in the number of cases of acute hepatitis of unknown origin (HUO) in children was observed in 2021. Adenovirus and adeno-associated virus 2 (AAV2) infections...
8.
Margulis M, Rohana H, Erster O, Mandelboim M, Biber A, Schwartz E, et al.
J Clin Microbiol
. 2024 May;
62(6):e0060024.
PMID: 38785448
Importance: Three years after the SARS-CoV-2 outbreak, there are no molecular tests that combine low-cost and straightforward sample preparation, effective sample handling, minimal reagent and disposable requirements, high sensitivity, and...
9.
Erster O, Bar-Or I, Azar R, Assraf H, Kabat A, Mannasse B, et al.
Sci Total Environ
. 2024 May;
933:173164.
PMID: 38735317
The emergence of the SARS-CoV-2 variant BA.2.86.1 raised a considerable concern, due to the large number of potentially virulent mutations. In this study, we developed a novel assay that specifically...
10.
Lustig Y, Canetti M, Indenbaum V, Peretz Y, Weiss-Ottolenghi Y, Margalit I, et al.
Emerg Infect Dis
. 2024 Apr;
30(5):1050-1052.
PMID: 38666742
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels....